PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CAH vs. AZN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CAH and AZN is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

CAH vs. AZN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cardinal Health, Inc. (CAH) and AstraZeneca PLC (AZN). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
16.38%
-13.19%
CAH
AZN

Key characteristics

Sharpe Ratio

CAH:

1.14

AZN:

0.85

Sortino Ratio

CAH:

1.65

AZN:

1.21

Omega Ratio

CAH:

1.22

AZN:

1.17

Calmar Ratio

CAH:

1.34

AZN:

0.61

Martin Ratio

CAH:

2.88

AZN:

1.28

Ulcer Index

CAH:

8.42%

AZN:

13.37%

Daily Std Dev

CAH:

21.36%

AZN:

20.27%

Max Drawdown

CAH:

-61.58%

AZN:

-48.94%

Current Drawdown

CAH:

-2.56%

AZN:

-14.91%

Fundamentals

Market Cap

CAH:

$30.62B

AZN:

$230.60B

EPS

CAH:

$5.37

AZN:

$2.25

PE Ratio

CAH:

23.60

AZN:

32.80

PEG Ratio

CAH:

0.94

AZN:

0.88

Total Revenue (TTM)

CAH:

$222.32B

AZN:

$54.07B

Gross Profit (TTM)

CAH:

$7.54B

AZN:

$43.87B

EBITDA (TTM)

CAH:

$2.45B

AZN:

$17.22B

Returns By Period

In the year-to-date period, CAH achieves a 8.17% return, which is significantly lower than AZN's 13.80% return. Over the past 10 years, CAH has underperformed AZN with an annualized return of 6.82%, while AZN has yielded a comparatively higher 11.24% annualized return.


CAH

YTD

8.17%

1M

-0.35%

6M

16.38%

1Y

22.90%

5Y*

19.90%

10Y*

6.82%

AZN

YTD

13.80%

1M

9.71%

6M

-13.19%

1Y

17.02%

5Y*

10.93%

10Y*

11.24%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CAH vs. AZN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CAH
The Risk-Adjusted Performance Rank of CAH is 7777
Overall Rank
The Sharpe Ratio Rank of CAH is 8080
Sharpe Ratio Rank
The Sortino Ratio Rank of CAH is 7474
Sortino Ratio Rank
The Omega Ratio Rank of CAH is 7373
Omega Ratio Rank
The Calmar Ratio Rank of CAH is 8484
Calmar Ratio Rank
The Martin Ratio Rank of CAH is 7272
Martin Ratio Rank

AZN
The Risk-Adjusted Performance Rank of AZN is 6767
Overall Rank
The Sharpe Ratio Rank of AZN is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of AZN is 6464
Sortino Ratio Rank
The Omega Ratio Rank of AZN is 6565
Omega Ratio Rank
The Calmar Ratio Rank of AZN is 7070
Calmar Ratio Rank
The Martin Ratio Rank of AZN is 6060
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CAH vs. AZN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cardinal Health, Inc. (CAH) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CAH, currently valued at 1.09, compared to the broader market-2.000.002.001.090.85
The chart of Sortino ratio for CAH, currently valued at 1.59, compared to the broader market-4.00-2.000.002.004.006.001.591.21
The chart of Omega ratio for CAH, currently valued at 1.21, compared to the broader market0.501.001.502.001.211.17
The chart of Calmar ratio for CAH, currently valued at 1.28, compared to the broader market0.002.004.006.001.280.61
The chart of Martin ratio for CAH, currently valued at 2.75, compared to the broader market-10.000.0010.0020.0030.002.751.28
CAH
AZN

The current CAH Sharpe Ratio is 1.14, which is higher than the AZN Sharpe Ratio of 0.85. The chart below compares the historical Sharpe Ratios of CAH and AZN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.50SeptemberOctoberNovemberDecember2025February
1.09
0.85
CAH
AZN

Dividends

CAH vs. AZN - Dividend Comparison

CAH's dividend yield for the trailing twelve months is around 1.59%, less than AZN's 3.37% yield.


TTM20242023202220212020201920182017201620152014
CAH
Cardinal Health, Inc.
1.59%1.28%1.98%2.57%3.80%3.62%3.79%4.24%2.99%2.41%1.68%1.65%
AZN
AstraZeneca PLC
3.37%2.27%2.15%2.14%2.40%2.80%2.81%3.61%3.95%5.01%4.06%3.98%

Drawdowns

CAH vs. AZN - Drawdown Comparison

The maximum CAH drawdown since its inception was -61.58%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for CAH and AZN. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-2.56%
-14.91%
CAH
AZN

Volatility

CAH vs. AZN - Volatility Comparison

Cardinal Health, Inc. (CAH) and AstraZeneca PLC (AZN) have volatilities of 5.53% and 5.76%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%SeptemberOctoberNovemberDecember2025February
5.53%
5.76%
CAH
AZN

Financials

CAH vs. AZN - Financials Comparison

This section allows you to compare key financial metrics between Cardinal Health, Inc. and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab